# Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects

> **NCT00930670** · PHASE4 · COMPLETED · sponsor: **Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec** · enrollment: 320 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Rosuvastatin-omeprazole
- **DRUG:** Rosuvastatin-pantoprazole
- **DRUG:** Rosuvastatin-esomeprazole
- **DRUG:** Rosuvastatin-ranitidine
- **DRUG:** Atorvastatin-omeprazole
- **DRUG:** Atorvastatin-pantoprazole
- **DRUG:** Atorvastatin-esomeprazole
- **DRUG:** Atorvastatin-ranitidine

## Key facts

- **NCT ID:** NCT00930670
- **Lead sponsor:** Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930670, "Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00930670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*